DEUTSCHE BANK AG\ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$90,815
-39.2%
53,7370.0%0.00%
Q2 2023$149,389
+45.9%
53,737
-4.5%
0.00%
Q1 2023$102,373
-51.2%
56,249
+35.9%
0.00%
Q4 2022$209,772
-24.3%
41,375
-25.7%
0.00%
Q3 2022$277,000
+77.6%
55,676
+33.0%
0.00%
Q2 2022$156,000
-27.8%
41,877
+8.7%
0.00%
Q1 2022$216,000
-16.9%
38,540
-10.0%
0.00%
Q4 2021$260,000
-39.3%
42,810
-2.6%
0.00%
Q3 2021$428,000
-32.5%
43,945
-1.0%
0.00%
Q2 2021$634,000
+16.3%
44,372
+93.3%
0.00%
Q1 2021$545,00022,9580.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders